Dr. Gbemudu received her B.S. in Biochemistry from Nova Southeastern University, her PharmD degree from University of Maryland, and MBA degree from University of Baltimore. She completed a one year post-doctoral fellowship with Rutgers University and Bristol Myers Squibb.
Dr. Shiel received a Bachelor of Science degree with honors from the University of Notre Dame. There he was involved in research in radiation biology and received the Huisking Scholarship. After graduating from St. Louis University School of Medicine, he completed his Internal Medicine residency and Rheumatology fellowship at the University of California, Irvine. He is board-certified in Internal Medicine and Rheumatology.
GENERIC NAME: aurothioglucose (This drug is discontinued in
BRAND NAME: Solganal
DRUG CLASS AND MECHANISM: Aurothioglucose is a
gold-containing chemical (salt) used for treating
arthritis. Other gold salts available include injectable
thiomalate (Myochrysine), and capsules,
(Ridaura). It is not well understood exactly how gold salts work. In patients
arthritis, such as adult and
rheumatoid arthritis, gold salts can decrease the inflammation of the joint
lining. This effect prevents the inflammation from destroying the bone and
cartilage surrounding the joints and prevents or slows the development of
deformities of the joints. Because of their ability to prevent deformities, gold
salts are referred to as disease modifying anti-rheumatic drugs (DMARDs). DMARDs
like aurothioglucose may take weeks to months to become effective.